Physician profile
George A Hill
NPI 1588696421
$1,139.03
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $507 · 2020: $159 · 2021: $173 · 2022: $153 · 2023: $17.49 · 2024: $130.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $147.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $147.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rochester Medical Corporation | $343.19 | 2019-2021 | |
| Arrow International, INC. | $129.96 | 2024 | |
| Tolmar Pharmaceuticals, INC. | $112.10 | 2022 | |
| Genzyme Corporation | $107.11 | 2019 | |
| Astellas Pharma US INC | $97.40 | 2019-2021 | |
| Boston Scientific Corporation | $91.39 | 2019-2021 | |
| Endo Pharmaceuticals INC. | $58.93 | 2019-2021 | |
| Neotract INC. | $37.60 | 2020 | |
| Novartis Pharmaceuticals Corporation | $36.40 | 2019 | |
| Janssen Biotech, INC. | $35.48 | 2019 | |
| Olympus America INC. | $35.15 | 2022-2023 | Itind System |
| Palette Life Sciences, INC. | $23.03 | 2022 | |
| Coloplast Corp | $18.57 | 2019 | |
| Emd Serono, INC. | $12.72 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Hill listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.